Related Experiment Video
Updated: Jul 10, 2026
09:45
Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
Published on: April 21, 2018
Advances in hymenoptera venom immunotherapy.
Beatrice M Bilò1, Floriano Bonifazi
1Department of Internal Medicine, Immunology, Allergy and Respiratory Diseases, University Hospital, Ancona, Italy. b.bilo@ao-umbertoprimo.marche.it
Current Opinion in Allergy and Clinical Immunology
|November 9, 2007
Summary
Venom immunotherapy effectively improves quality of life. Advances in immunological mechanisms and treatment protocols offer personalized care, but further research is needed for optimal patient outcomes.
Area of Science:
- Immunology
- Allergy and Clinical Immunology
- Pharmacology
Background:
- Venom immunotherapy (VIT) is a cornerstone treatment for venom allergy.
- It significantly improves health-related quality of life for affected individuals.
- Understanding VIT's immunological basis is crucial for optimizing treatment.
Purpose of the Study:
- To review recent advancements in venom immunotherapy.
- To examine new findings on immunological mechanisms and efficacy.
- To discuss practical considerations for treatment initiation and discontinuation.
Main Methods:
- Literature review of recent studies on venom immunotherapy.
- Analysis of immunological mechanisms underlying VIT efficacy.
- Evaluation of clinical data on treatment protocols and side effects.
Main Results:
- New insights into early and long-term immunological efficacy of VIT.
- Treatment decisions should be individualized, considering quality of life.
- Geographical venom selection and cross-reactivity are important; rapid protocols are safe but side effects persist.
- Mast cell disease patients may have higher risks, but efficacy is maintained.
Conclusions:
- Significant progress has been made in venom immunotherapy.
- Further research and development are necessary to optimize treatments and address remaining challenges.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:26Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.